Liver-related adverse drug reactions were nearly three times more common than kidney-related adverse drug reactions in patients with rheumatoid arthritis (RA) using methotrexate; however, fatal ...
Please provide your email address to receive an email when new articles are posted on . In 2023, nearly a third of hospitalized patients with chronic liver disease had acute kidney injury or ...
Stockhead on MSN
Health check: CSL places $500m-plus bet on rare kidney and liver disease drug candidate
CSL will pay an upfront US$355 million ($515m) to co-develop an external drug candidate aimed at treating rare kidney and ...
A common liver condition thought to be harmless could be dramatically increasing the risk of heart disease, kidney failure and premature death, according to a new review led by University of ...
Vietnam Investment Review on MSN
CSL secures lixudebart licensing deal with Alentis for 355 million dollars
MELBOURNE, Australia and BASEL, Switzerland, Oct. 5, 2026 /PRNewswire/ -- CSL and Alentis Therapeutics today announced they have entered into an exclusive global collaboration agreement to co-develop ...
Auxilium Biotechnologies has bioprinted kidney and liver tissue aboard the International Space Station. It says that is the first time anyone has made either in space. The samples flew home last month ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results